{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T06:35:26Z","timestamp":1780814126259,"version":"3.54.1"},"reference-count":58,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1G1A1100578"],"award-info":[{"award-number":["NRF-2019R1G1A1100578"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Mesonephric-like adenocarcinoma (MLA) of the uterine corpus is a rare but distinct malignant tumor of the female genital tract, demonstrating a characteristic morphology and unique immunohistochemical profiles and molecular alterations. We conducted immunohistochemical staining (IHC) to make precise differential diagnoses of uterine MLAs from common histological subtypes of endometrial carcinomas. We collected 25 uterine MLAs and performed IHC for GATA3, TTF1, CD10, ER, PR, p16, p53, and HER2. Seventeen cases (68.0%) showed at least moderate nuclear GATA3 immunoreactivity in \u226525% of tumor cells. Most cases expressed TTF1 (17\/21, 81.0%) and CD10 (luminal; 17\/21, 81.0%). Heterogeneous TTF1 expression was noted in 12 cases. An inverse pattern of GATA3 and TTF1 staining was observed in eight cases (32.0%). Three cases (12.0%) showed moderate-to-strong ER expression in \u226525% of tumor cells, and two cases (8.0%) showed moderate-to-strong PR expression in \u22655% of tumor cells. These hormone receptor-positive MLAs varied in intensity and proportion of GATA3 staining. None of the 25 cases exhibited either diffuse and strong p16 expression or aberrant p53 expression. Five cases (20.0%) showed equivocal HER2 immunoreactivity (score 2+), but HER2 FISH confirmed that none of them exhibited HER2 gene amplification. In summary, a small subset of uterine MLAs displayed atypical IHC results: focal but strong expression of ER or PR, the complete absence of GATA3 immunoreactivity, the concurrent expression of mesonephric and hormone receptors, and the inverse pattern of GATA3 and TTF1 staining. These unusual immunophenotypes may complicate the differential diagnosis of MLA. Moreover, pathologists should be encouraged to interpret the IHC results cautiously.<\/jats:p>","DOI":"10.3390\/diagnostics11112042","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T09:11:32Z","timestamp":1636017092000},"page":"2042","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Immunohistochemical Analyses Using Markers for Mesonephric, Endometrioid and Serous Tumors"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8336-881X","authenticated-orcid":false,"given":"Hyunjin","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4220-6755","authenticated-orcid":false,"given":"Kiyong","family":"Na","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul 02447, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9288-1383","authenticated-orcid":false,"given":"Go Eun","family":"Bae","sequence":"additional","affiliation":[{"name":"Department of Pathology, Chungnam National University School of Medicine, Daejeon 35015, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4730-221X","authenticated-orcid":false,"given":"Hyun-Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAS.0000000000000991","article-title":"Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body","volume":"43","author":"Na","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e000480","DOI":"10.1136\/esmoopen-2018-000480","article-title":"Controversies in oncology: Are genomic tests quantifying homologous recombination repair deficiency (HRD) useful for treatment decision making?","volume":"4","author":"Pellegrino","year":"2019","journal-title":"ESMO Open"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cncy.22160","article-title":"Cytologic features of upper gynecologic tract adenocarcinomas exhibiting mesonephric-like differentiation","volume":"127","author":"Kezlarian","year":"2019","journal-title":"Cancer Cytopathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.12895","article-title":"Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: Report of a series of mesonephric-like adenocarcinomas","volume":"68","author":"McFarland","year":"2016","journal-title":"Histopathology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/PAS.0000000000001401","article-title":"Mesonephric-like carcinoma of the endometrium: A subset of endometrial carcinoma with an aggressive behavior","volume":"44","author":"Euscher","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00432-019-03123-7","article-title":"Mesonephric-like adenocarcinomas of the uterine corpus: Report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma","volume":"146","author":"Horn","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/PAS.0000000000001612","article-title":"Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract","volume":"45","author":"Pors","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Choi, S., Jung, Y.Y., and Kim, H.S. (2021). Serous carcinoma of the endometrium with mesonephric-like differentiation initially misdiagnosed as uterine mesonephric-like adenocarcinoma: A case report with emphasis on the immunostaining and the identification of splice site TP53 mutation. Diagnostics, 11.","DOI":"10.3390\/diagnostics11040717"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.21873\/anticanres.15053","article-title":"Dedifferentiated Mesonephric-like Adenocarcinoma of the Uterine Corpus","volume":"41","author":"Choi","year":"2021","journal-title":"Anticancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.21873\/cgp.20235","article-title":"Atypical Mesonephric Hyperplasia of the Uterus Harbors Pathogenic Mutation of Kirsten Rat Sarcoma 2 Viral Oncogene Homolog (KRAS) and Gain of Chromosome 1q","volume":"17","author":"Kim","year":"2020","journal-title":"Cancer Genom. Proteom."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAS.0000000000001193","article-title":"A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the Endometrium","volume":"43","author":"Kolin","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1097\/PAS.0000000000001142","article-title":"A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract","volume":"42","author":"Pors","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/PAS.0000000000000958","article-title":"Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract","volume":"42","author":"Mirkovic","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pathol.2017.11.084","article-title":"Mesonephric proliferations of the female genital tract","volume":"50","author":"Howitt","year":"2018","journal-title":"Pathology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/modpathol.2015.103","article-title":"Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract","volume":"28","author":"Mirkovic","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4132\/jptm.2018.08.30","article-title":"TFE3-Expressing Perivascular Epithelioid Cell Tumor of the Breast","volume":"53","author":"Kim","year":"2019","journal-title":"J. Pathol. Transl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4132\/jptm.2019.02.21","article-title":"A Rare Case of Adenosquamous Carcinoma Arising in the Background of IgG4-Related Lung Disease","volume":"53","author":"Choi","year":"2019","journal-title":"J. Pathol. Transl. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4132\/jptm.2020.12.11","article-title":"Adenocarcinoma of the minor salivary gland with concurrent MAML2 and EWSR1 alterations","volume":"55","author":"Choi","year":"2021","journal-title":"J. Pathol. Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.21873\/anticanres.14918","article-title":"Prominent Papillary Growth Pattern and Severe Nuclear Pleomorphism Induced by Neoadjuvant Chemotherapy in Ovarian Mucinous Carcinoma: Potential for Misdiagnosis as High-grade Serous Carcinoma","volume":"41","author":"Kwon","year":"2021","journal-title":"Anticancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.21873\/invivo.12499","article-title":"Clinicopathological Characteristics of Gastric-type Endocervical Adenocarcinoma Misdiagnosed as an Endometrial, Ovarian or Extragenital Malignancy, or Mistyped as Usual-type Endocervical Adenocarcinoma","volume":"35","author":"Koh","year":"2021","journal-title":"Vivo"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.21873\/invivo.12527","article-title":"Clinicopathological Characteristics of Microscopic Tubal Intraepithelial Metastases from Adenocarcinoma and Small Cell Neuroendocrine Carcinoma of the Uterine Cervix","volume":"35","author":"Lee","year":"2021","journal-title":"Vivo"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.21873\/anticanres.14093","article-title":"Clinicopathological and Prognostic Significance of Programmed Death Ligand 1 Expression in Korean Patients With Triple-negative Breast Carcinoma","volume":"40","author":"Kim","year":"2020","journal-title":"Anticancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.21873\/anticanres.14271","article-title":"Primary Peritoneal High-grade Serous Carcinoma Misinterpreted as Metastatic Breast Carcinoma: A Rare Encounter in Peritoneal Fluid Cytology","volume":"40","author":"Park","year":"2020","journal-title":"Anticancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.21873\/cgp.20219","article-title":"Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the Uterine Cervix","volume":"17","author":"Jung","year":"2020","journal-title":"Cancer Genom. Proteom."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Choi, S., Joo, J.W., Do, S.I., and Kim, H.S. (2020). Endometrium-limited metastasis of extragenital malignancies: A challenge in the diagnosis of endometrial curettage specimens. Diagnostics, 10.","DOI":"10.3390\/diagnostics10030150"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.21873\/invivo.12079","article-title":"Clinicopathological Characteristics of Squamous Cell Carcinoma and High-grade Squamous Intraepithelial Lesions Involving Endocervical Polyps","volume":"34","author":"Park","year":"2020","journal-title":"Vivo"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4132\/jptm.2019.10.24","article-title":"Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breast","volume":"54","author":"Jang","year":"2020","journal-title":"J. Pathol. Transl. Med."},{"key":"ref_28","first-page":"4244s","article-title":"Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors","volume":"46","author":"Mccarty","year":"1986","journal-title":"Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1200\/JCO.2003.11.069","article-title":"Epidermal Growth Factor Receptor in Non\u2013Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on Prognosis","volume":"21","author":"Hirsch","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","article-title":"Interpretation of p53 immunohistochemistry in endometrial carcinomas: Toward increased reproducibility","volume":"38","author":"Kobel","year":"2019","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/PGP.0000000000000711","article-title":"HER2 Testing and Reporting in Endometrial Serous Carcinoma: Practical Recommendations for HER2 Immunohistochemistry and Fluorescent In Situ Hybridization: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting","volume":"40","author":"Buza","year":"2021","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s40291-016-0205-4","article-title":"A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer","volume":"20","author":"Ahn","year":"2016","journal-title":"Mol. Diagn. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4048\/jbc.2017.20.3.286","article-title":"NanoString nCounter\u00ae Approach in Breast Cancer: A Comparative Analysis with Quantitative Real-Time Polymerase Chain Reaction, In Situ Hybridization, and Immunohistochemistry","volume":"20","author":"Hyeon","year":"2017","journal-title":"J. Breast Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"921","DOI":"10.21873\/invivo.12332","article-title":"Diagnostic Utility of Oncomine Comprehensive Assay v3 in Differentiating Between Isocitrate Dehydrogenase (IDH)-mutated Grade II-III Astrocytoma and Oligodendroglioma","volume":"35","author":"Kim","year":"2021","journal-title":"Vivo"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/s41379-021-00799-6","article-title":"Mesonephric and mesonephric-like carcinomas of the female genital tract: Molecular characterization including cases with mixed histology and matched metastases","volume":"34","author":"Fix","year":"2021","journal-title":"Mod. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Deolet, E., Van Dorpe, J., and Van de Vijver, K. (2021). Mesonephric-like Adenocarcinoma of the Endometrium: Diagnostic Advances to Spot This Wolf in Sheep\u2019s Clothing. A Review of the Literature. J. Clin. Med., 10.","DOI":"10.3390\/jcm10040698"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/modpathol.3800620","article-title":"Immunophenotypic diversity of endometrial adenocarcinomas: Implications for differential diagnosis","volume":"19","author":"Iyengar","year":"2006","journal-title":"Mod. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"506","DOI":"10.18632\/oncotarget.13471","article-title":"Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer?","volume":"8","author":"Shen","year":"2016","journal-title":"Oncotarget"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31824a72c6","article-title":"Mesonephric adenocarcinomas of the uterine cervix and corpus: HPV-negative neoplasms that are commonly PAX8, CA125, and HMGA2 positive and that may be immunoreactive with TTF1 and hepatocyte nuclear factor 1-beta","volume":"36","author":"Kenny","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/his.13798","article-title":"Pulmonary metastasis of mesonephric-like adenocarcinoma arising from the uterine body: A striking mimic of follicular thyroid carcinoma","volume":"74","author":"Yamamoto","year":"2019","journal-title":"Histopathology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/PGP.0000000000000493","article-title":"Mesonephric adenocarcinoma of the uterine corpus: Report of 2 cases and review of the literature","volume":"38","author":"Zhang","year":"2019","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Park, S., Bae, G.E., Kim, J., and Kim, H.S. (2021). Mesonephric-like differentiation of endometrial endometrioid carcinoma: Clinicopathological and molecular characteristics distinct from those of uterine mesonephric-like adenocarcinoma. Diagnostics, 11.","DOI":"10.3390\/diagnostics11081450"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13000-019-0830-4","article-title":"Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Mullerian duct lineage: A case report","volume":"14","author":"Yano","year":"2019","journal-title":"Diagn. Pathol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/PAS.0b013e3181ac35f5","article-title":"Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: Immunohistochemical analysis of 201 cases","volume":"33","author":"Yemelyanova","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.5858\/arpa.2020-0207-RA","article-title":"HER2 Testing in Endometrial Serous Carcinoma: Time for Standardized Pathology Practice to Meet the Clinical Demand","volume":"145","author":"Buza","year":"2021","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: A multispecific but potentially useful marker in surgical pathology: A systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/his.14015","article-title":"Incorporation of molecular characteristics into endometrial cancer management","volume":"76","author":"Vermij","year":"2020","journal-title":"Histopathology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Santoro, A., Angelico, G., Travaglino, A., Inzani, F., Arciuolo, D., Valente, M., D\u2019Alessandris, N., Scaglione, G., Fiorentino, V., and Raffone, A. (2021). New pathological and clinical insights in endometrial cancer in view of the updated ESGO\/ESTRO\/ESP Guidelines. Cancers, 13.","DOI":"10.3390\/cancers13112623"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"D\u2019Amati, A., Pezzuto, F., Serio, G., Marzullo, A., Fortarezza, F., Lettini, T., Cazzato, G., Cormio, G., and Resta, L. (2021). Mesonephric-like carcinosarcoma of the ovary associated with low-grade serous carcinoma: A case report. Diagnostics, 11.","DOI":"10.3390\/diagnostics11050827"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e227050","DOI":"10.1136\/bcr-2018-227050","article-title":"Carcinosarcoma of the uterine cervix: A rare pathological finding originating from mesonephric remnants","volume":"12","author":"Ribeiro","year":"2019","journal-title":"BMJ Case Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/PGP.0000000000000088","article-title":"Mesonephric carcinosarcoma involving uterine cervix and vagina: Report of 2 cases with immunohistochemical positivity For PAX2, PAX8, and GATA-3","volume":"33","author":"Roma","year":"2014","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1746-1596-8-74","article-title":"Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: A case report and review of the literature","volume":"8","author":"Meguro","year":"2013","journal-title":"Diagn. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1440-1827.1995.tb03461.x","article-title":"Carcinosarcoma of the uterine body of mesonephric origin","volume":"45","author":"Yamamoto","year":"1995","journal-title":"Pathol. Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/modpathol.2011.88","article-title":"Molecular markers and clinical behavior of uterine carcinosarcomas: Focus on the epithelial tumor component","volume":"24","author":"Nijman","year":"2011","journal-title":"Mod. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00428-019-02532-w","article-title":"Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas","volume":"475","author":"Franceschi","year":"2019","journal-title":"Virchows Arch"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/ijgc-2018-000038","article-title":"Immunohistochemical analysis of the epithelial to mesenchymal transition in uterine carcinosarcoma","volume":"29","author":"Osakabe","year":"2019","journal-title":"Int. J. Gynecol. Cancer"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/11\/11\/2042\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:25:51Z","timestamp":1760167551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/11\/11\/2042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,4]]},"references-count":58,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["diagnostics11112042"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics11112042","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,4]]}}}